| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 27, 2003
Accepted on August 5, 2003
1 Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, and Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL; Department of Pathology, Emory University School of Medicine, Atlanta, GA; Department of Physiology and Functional Genomics, University of Florida College of Medicine, Gainesville, FL; Endocrinology Section, Medical Service, Veterans Affairs Medical Center, Birmingham, AL
* To whom correspondence should be addressed. E-mail: sjfrank{at}uab.edu.
GH signaling depends on functional interaction of the GH receptor (GHR) and the cytoplasmic tyrosine kinase, JAK2, which possesses a C-terminal kinase domain, a catalytically-inactive pseudokinase domain just N-terminal to the kinase domain, and an N-terminal half shown by us and others to harbor elements for GHR association. Computational analyses indicate that JAKs contain in their N-termini (
450 residues) divergent FERM domains. FERM domains (or subdomains within them) in JAKS may be important for associations with cytokine receptors. For some cytokine receptors, JAK interaction may be required for receptor surface expression. We previously demonstrated that a JAK2 mutant devoid of its N-terminal 239 residues (JAK2-
1-239) did not associate with GHR and could not mediate GH-induced signaling. In this report, we employ a JAK2-deficient cell line to further define N-terminal JAK2 regions required for physical and functional association with the GHR. We also examine whether JAK2 expression affects cell surface expression of the GHR. Our results suggest that FERM motifs play an important role in the interaction of GHR and JAK2. While JAK2 expression is not required for detectable surface GHR expression, increased JAK2 level increases the fraction of GHRs that achieves resistance to deglycosylation by endoglycosidase H, suggesting that the GHR-JAK2 association may enhance either the receptor's efficiency of maturation or its stability. Further, we report evidence for the existence of a novel GH-inducible functional interaction between JAK2 molecules that may be important in the mechanism of GH-triggered JAK2 signaling.
This article has been cited by other articles:
![]() |
J. Zheng, J. E. Koblinski, L. V. Dutson, Y. B. Feeney, and C. V. Clevenger Prolyl Isomerase Cyclophilin A Regulation of Janus-Activated Kinase 2 and the Progression of Human Breast Cancer Cancer Res., October 1, 2008; 68(19): 7769 - 7778. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yang, J. F. Langenheim, X. Wang, J. Jiang, W. Y. Chen, and S. J. Frank Activation of Growth Hormone Receptors by Growth Hormone and Growth Hormone Antagonist Dimers: Insights into Receptor Triggering Mol. Endocrinol., April 1, 2008; 22(4): 978 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Loesch, L. Deng, X. Wang, K. He, J. Jiang, and S. J. Frank Endoplasmic Reticulum-Associated Degradation of Growth Hormone Receptor in Janus Kinase 2-Deficient Cells Endocrinology, December 1, 2007; 148(12): 5955 - 5965. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ravid, I. Shams, N. Ben Califa, E. Nevo, A. Avivi, and D. Neumann An extracellular region of the erythropoietin receptor of the subterranean blind mole rat Spalax enhances receptor maturation PNAS, September 4, 2007; 104(36): 14360 - 14365. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Asa, R. DiGiovanni, J. Jiang, M. L. Ward, K. Loesch, S. Yamada, T. Sano, K. Yoshimoto, S. J. Frank, and S. Ezzat A Growth Hormone Receptor Mutation Impairs Growth Hormone Autofeedback Signaling in Pituitary Tumors Cancer Res., August 1, 2007; 67(15): 7505 - 7511. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yang, X. Wang, J. Jiang, and S. J. Frank Role of the Growth Hormone (GH) Receptor Transmembrane Domain in Receptor Predimerization and GH-Induced Activation Mol. Endocrinol., July 1, 2007; 21(7): 1642 - 1655. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Deng, K. He, X. Wang, N. Yang, C. Thangavel, J. Jiang, S. Y. Fuchs, and S. J. Frank Determinants of Growth Hormone Receptor Down-Regulation Mol. Endocrinol., July 1, 2007; 21(7): 1537 - 1551. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Murray The JAK-STAT Signaling Pathway: Input and Output Integration J. Immunol., March 1, 2007; 178(5): 2623 - 2629. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pelletier, S. Gingras, M. Funakoshi-Tago, S. Howell, and J. N. Ihle Two Domains of the Erythropoietin Receptor Are Sufficient for Jak2 Binding/Activation and Function Mol. Cell. Biol., November 15, 2006; 26(22): 8527 - 8538. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Frank, X. Wang, K. He, N. Yang, P. Fang, R. G. Rosenfeld, V. Hwa, T. R. Chaudhuri, L. Deng, and K. R. Zinn In Vivo Imaging of Hepatic Growth Hormone Signaling Mol. Endocrinol., November 1, 2006; 20(11): 2819 - 2830. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, Q. Zhang, A. Tengholm, and A. Sjoholm Involvement of JAK2 and Src kinase tyrosine phosphorylation in human growth hormone-stimulated increases in cytosolic free Ca2+ and insulin secretion Am J Physiol Cell Physiol, September 1, 2006; 291(3): C466 - C475. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Loesch, L. Deng, J. W. Cowan, X. Wang, K. He, J. Jiang, R. A. Black, and S. J. Frank Janus Kinase 2 Influences Growth Hormone Receptor Metalloproteolysis Endocrinology, June 1, 2006; 147(6): 2839 - 2849. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Radtke, A. Jorissen, H. S.-V. de Leur, P. C. Heinrich, and I. Behrmann Three Dileucine-like Motifs within the Interbox1/2 Region of the Human Oncostatin M Receptor Prevent Efficient Surface Expression in the Absence of an Associated Janus Kinase J. Biol. Chem., February 17, 2006; 281(7): 4024 - 4034. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Lucet, E. Fantino, M. Styles, R. Bamert, O. Patel, S. E. Broughton, M. Walter, C. J. Burns, H. Treutlein, A. F. Wilks, et al. The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor Blood, January 1, 2006; 107(1): 176 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. He, K. Loesch, J. W. Cowan, X. Li, L. Deng, X. Wang, J. Jiang, and S. J. Frank Janus Kinase 2 Enhances the Stability of the Mature Growth Hormone Receptor Endocrinology, November 1, 2005; 146(11): 4755 - 4765. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Alblas, H. Honing, C. Renardel de Lavalette, M. H. Brown, C. D. Dijkstra, and T. K. van den Berg Signal Regulatory Protein {alpha} Ligation Induces Macrophage Nitric Oxide Production through JAK/STAT- and Phosphatidylinositol 3-Kinase/Rac1/NAPDH Oxidase/H2O2-Dependent Pathways Mol. Cell. Biol., August 15, 2005; 25(16): 7181 - 7192. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Cowan, X. Wang, R. Guan, K. He, J. Jiang, G. Baumann, R. A. Black, M. S. Wolfe, and S. J. Frank Growth Hormone Receptor Is a Target for Presenilin-dependent {gamma}-Secretase Cleavage J. Biol. Chem., May 13, 2005; 280(19): 19331 - 19342. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jiang, X. Wang, K. He, X. Li, C. Chen, P. P. Sayeski, M. J. Waters, and S. J. Frank A Conformationally Sensitive GHR [Growth Hormone (GH) Receptor] Antibody: Impact on GH Signaling and GHR Proteolysis Mol. Endocrinol., December 1, 2004; 18(12): 2981 - 2996. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Wallace, D. VonDerLinden, K. He, S. J. Frank, and P. P. Sayeski Microarray analyses identify JAK2 tyrosine kinase as a key mediator of ligand-independent gene expression Am J Physiol Cell Physiol, October 1, 2004; 287(4): C981 - C991. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Huang, S.-O. Kim, N. Yang, J. Jiang, and S. J. Frank Physical and Functional Interaction of Growth Hormone and Insulin-Like Growth Factor-I Signaling Elements Mol. Endocrinol., June 1, 2004; 18(6): 1471 - 1485. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yang, Y. Huang, J. Jiang, and S. J. Frank Caveolar and Lipid Raft Localization of the Growth Hormone Receptor and Its Signaling Elements: IMPACT ON GROWTH HORMONE SIGNALING J. Biol. Chem., May 14, 2004; 279(20): 20898 - 20905. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |